TTI1 Antibodies

Santa Cruz Biotechnology features a diverse variety of TTI1 monoclonal antibodies for investigating TTI1's role in cellular processes. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TTI1 functions as a critical component of the mTOR signaling pathway, which regulates cell growth, proliferation, and survival. As part of the mTOR complex 1 (mTORC1), TTI1 plays an essential role in maintaining proper pathway function. Research has shown that TTI1 activity significantly impacts various diseases, including cancer and metabolic disorders. Scientists worldwide use TTI1 monoclonal antibodies to advance their understanding of cellular signaling mechanisms. Ongoing studies continue to reveal new insights about TTI1's involvement in health and disease. Current research focuses on how TTI1 interacts with other proteins in the mTOR pathway. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific knowledge and potential therapeutic developments in the field of cell signaling.